Amgen revenue decreased from $23.7 billion in 2018 to $23.4 billion in 2019, a (1.6%) decrease.

Annual Revenue ($)

Amgen revenue was $23.36 b in FY, 2019 which is a (1.6%) year over year decrease from the previous period.

Quarterly Revenue ($)

FY, 2016FY, 2017FY, 2018FY, 2019
Revenue$22.99 b$22.85 b$23.75 b$23.36 b
Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020
Revenue$5.46 b$5.81 b$5.77 b$5.55 b$6.06 b$5.9 b$5.56 b$5.87 b$5.74 b$6.16 b$6.21 b$6.42 b

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Geographic Segment

Amgen revenue breakdown by business segment: 22.4% from Enbrel, 13.8% from Neulasta, 11.4% from Prolia, 8.3% from XGEVA, 7.4% from Aranesp, 21.2% from Other products and 15.5% from Other

Amgen revenue breakdown by geographic segment: 25.5% from Rest of World and 74.5% from United States

FY, 2019FY, 2018FY, 2017
Enbrel$5.23 b$5.01 b$5.36 b
Neulasta$3.22 b$4.48 b$4.72 b
Prolia$2.67 b$2.29 b$1.31 b
XGEVA$1.94 b$1.79 b$1.41 b
Aranesp$1.73 b$1.88 b$951 m
KYPROLIS$1.04 b$512 m
EPOGEN$867 m$1.01 b$1.86 b
Sensipar/Mimpara$551 m$1.77 b$1.42 b
Other products$4.96 b$4.31 b$2.41 b
Other revenues$1.16 b$1.21 b$718 m
FY, 2019FY, 2018FY, 2017FY, 2016
Rest of World$5.67 b$5.1 b$4.66 b$4.57 b
United States$16.53 b$17.43 b$17.13 b$17.33 b

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu